Torene, R., Nirmala, N., Obici, L., Cattalini, M., Tormey, V., Caorsi, R., . . . Gattorno, M. (2017). Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome. Ann Rheum Dis.
Citación estilo ChicagoTorene, Rebecca, et al. "Canakinumab Reverses Overexpression of Inflammatory Response Genes in Tumour Necrosis Factor Receptor-associated Periodic Syndrome." Ann Rheum Dis 2017.
Cita MLATorene, Rebecca, et al. "Canakinumab Reverses Overexpression of Inflammatory Response Genes in Tumour Necrosis Factor Receptor-associated Periodic Syndrome." Ann Rheum Dis 2017.
Precaución: Estas citas no son 100% exactas.